The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
miR-155 : On the Crosstalk Between Inflammation and Cancer
Abstract
MicroRNAs are short non-coding RNAs that posttranscriptionally modulate the expression of multiple target genes and are thus implicated in a wide array of cellular and developmental processes. miR-155 is processed from BIC, a non-coding transcript highly expressed in both activated B and T cells and in monocytes/macrophages. miR-155 levels change dynamically during both hematopoietic lineage differentiation and the course of the immune response. Different mouse models developed recently indicate that miR-155 plays a critical role during hematopoiesis and regulates lymphocyte homeostasis and tolerance. A moderate increase of miR-155 levels is observed in many types of malignancies of B cell or myeloid origin, and transgenic over-expression of miR-155 in mice results in cancer. While the high levels of miR-155 reached transiently during the course of the immune response remain unharmful for the organism, the reason why a moderate up-regulation of miR-155 can lead to cancer remains obscure. As prolonged exposure to inflammation can lead to cancer, the permanent up-regulation of miR-155 might be a link between the two. Therefore, designing miR-155 based therapies will require a better understanding of the molecular basis of its action as well as of how miR-155 levels are regulated in a cell-specific manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
MicroRNA-155 Regulates Human Angiotensin II Type 1 Receptor Expression in Fibroblasts
Martin, M. M., Lee, E. J., Buckenberger, J. A., Schmittgen, T. D., & Elton, T. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601496200 · Cited by 225
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Self-citationA microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Self-citationMuramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Self-citationMicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Requirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833
Regulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., Lund, E., & Dahlberg, J. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500613102 · Cited by 1,325
Tili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5082 · Cited by 1,304
Self-citationFoxp3-dependent programme of regulatory T-cell differentiation
Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A., & Rudensky, A. Y. (2007) · Nature · doi:10.1038/nature05543 · Cited by 1,135
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 951
Self-citationGerminal centres: role in B-cell physiology and malignancy
Klein, U., & Dalla-Favera, R. (2008) · Nature Reviews Immunology · doi:10.1038/nri2217 · Cited by 901
Lu, L.-F., Thai, T.-H., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G. B., Lee, H., Yoshimura, A., Rajewsky, K., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.010 · Cited by 783
microRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells
Vigorito, E., Perks, K. L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, P. P., Miska, E. A., Rodriguez, A., Bradley, A., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.009 · Cited by 763
Foxp3 occupancy and regulation of key target genes during T-cell stimulation
Marson, A., Kretschmer, K., Frampton, G. M., Jacobsen, E. S., Polansky, J. K., MacIsaac, K. D., Levine, S. S., Fraenkel, E., von Boehmer, H., & Young, R. A. (2007) · Nature · doi:10.1038/nature05478 · Cited by 724
Foxp3 in control of the regulatory T cell lineage
Zheng, Y., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1455 · Cited by 701
Kong, W., Yang, H., He, L., Zhao, J.-J., Coppola, D., Dalton, W. S., & Cheng, J. Q. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-08 · Cited by 689
O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J., Paquette, R. L., & Baltimore, D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072108 · Cited by 681 · cited 5×
“A following report showed that the enforced expression of miR-155 in hematopoietic stem cells subsequently engrafted into lethally irradiated mice resulted in a myeloproliferative disorder of the bone marrow [19].”
BackgroundInfluentialKluiver, J., Poppema, S., de Jong, D., Blokzijl, T., Harms, G., Jacobs, S., Kroesen, B., & van den Berg, A. (2005) · The Journal of Pathology · doi:10.1002/path.1825 · Cited by 672
A viral microRNA functions as an orthologue of cellular miR-155
Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W. H., Chi, J.-T. A., Braich, R., Manoharan, M., Soutschek, J., Ohler, U., et al. (2007) · Nature · doi:10.1038/nature05992 · Cited by 566
Gironella, M., Seux, M., Xie, M.-J., Cano, C., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K.-T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 551
A role for Dicer in immune regulation
Cobb, B. S., Hertweck, A., Smith, J., O'Connor, E., Graf, D., Cook, T., Smale, S. T., Sakaguchi, S., Livesey, F. J., Fisher, A. G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061692 · Cited by 522
Georgantas, R. W., Hildreth, R., Morisot, S., Alder, J., Liu, C.-G., Heimfeld, S., Calin, G. A., Croce, C. M., & Civin, C. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610983104 · Cited by 491
Self-citationMicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation
Dorsett, Y., McBride, K. M., Jankovic, M., Gazumyan, A., Thai, T.-H., Robbiani, D. F., Di Virgilio, M., San-Martin, B. R., Heidkamp, G., Schwickert, T. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.002 · Cited by 458
Distinct Thresholds Govern Myc's Biological Output In Vivo
Murphy, D. J., Junttila, M. R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D. A., Brown-Swigart, L., Johnson, L., & Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.018 · Cited by 456
MicroRNA-155 Is a Negative Regulator of Activation-Induced Cytidine Deaminase
Teng, G., Hakimpour, P., Landgraf, P., Rice, A., Tuschl, T., Casellas, R., & Papavasiliou, F. N. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.015 · Cited by 447
Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155
Skalsky, R. L., Samols, M. A., Plaisance, K. B., Boss, I. W., Riva, A., Lopez, M. C., Baker, H. V., & Renne, R. (2007) · Journal of Virology · doi:10.1128/jvi.01804-07 · Cited by 445
Lawrie, C. H., Soneji, S., Marafioti, T., Cooper, C. D. O., Palazzo, S., Paterson, J. C., Cattan, H., Enver, T., Mager, R., Boultwood, J., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22800 · Cited by 409
Costinean, S., Sandhu, S. K., Pedersen, I. M., Tili, E., Trotta, R., Perrotti, D., Ciarlariello, D., Neviani, P., Harb, J., Kauffman, L. R., et al. (2009) · Blood · doi:10.1182/blood-2009-05-220814 · Cited by 292
Self-citationTam, W., Ben-Yehuda, D., & Hayward, W. S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1490 · Cited by 285
Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., Cameron, J., & Flemington, E. K. (2008) · Journal of Virology · doi:10.1128/jvi.02380-07 · Cited by 261
Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S., & Mallardo, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn666 · Cited by 254
B-cell Receptor Activation Induces BIC/miR-155 Expression through a Conserved AP-1 Element
Yin, Q., Wang, X., McBride, J., Fewell, C., & Flemington, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708218200 · Cited by 232
High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma
van den Berg, A., Kroesen, B., Kooistra, K., de Jong, D., Briggs, J., Blokzijl, T., Jacobs, S., Kluiver, J., Diepstra, A., Maggio, E., et al. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10186 · Cited by 232
Ovcharenko, D., Kelnar, K., Johnson, C., Leng, N., & Brown, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1484 · Cited by 224
Lack of BIC and microRNA miR‐155 expression in primary cases of Burkitt lymphoma
Kluiver, J., Haralambieva, E., de Jong, D., Blokzijl, T., Jacobs, S., Kroesen, B., Poppema, S., & van den Berg, A. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20273 · Cited by 214
Lu, F., Weidmer, A., Liu, C.-G., Volinia, S., Croce, C. M., & Lieberman, P. M. (2008) · Journal of Virology · doi:10.1128/jvi.00752-08 · Cited by 190
Self-citationHaasch, D., Chen, Y.-W., Reilly, R. M., Grace Chiou, X., Koterski, S., Smith, M. L., Kroeger, P., McWeeny, K., Halbert, D. N., Mollison, K. W., et al. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00506-3 · Cited by 189
Clurman, B. E., & Hayward, W. S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2657 · Cited by 179
Tam, W., Hughes, S. H., Hayward, W. S., & Besmer, P. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4275-4286.2002 · Cited by 168
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma
Kluiver, J. L., van den Berg, A., de Jong, D., Blokzijl, T., Harms, G., Bouwman, E., Jacobs, S. C., Poppema, S., & Kroesen, B. J. (2006) · Oncogene · doi:10.1038/sj.onc.1210147 · Cited by 155
A Functional MicroRNA-155 Ortholog Encoded by the Oncogenic Marek's Disease Virus
Zhao, Y., Yao, Y., Xu, H., Lambeth, L. S., Smith, L. P., Kgosana, L. B., Wang, X., & Nair, V. (2008) · Journal of Virology · doi:10.1128/jvi.01166-08 · Cited by 148
MicroRNAs, the immune system and rheumatic disease
Tili, E., Michaille, J., Costinean, S., & Croce, C. M. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0885 · Cited by 143
Self-citationCoordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma
Rai, D., Karanti, S., Jung, I., Dahia, P. L. M., & Aguiar, R. C. T. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.10.008 · Cited by 142
Sequence Conservation and Differential Expression of Marek's Disease Virus MicroRNAs
Morgan, R. W., Anderson, A., Bernberg, E. L., Kamboj, S., Huang, E., Lagasse, G., Isaacs, G., Parcells, M. S., Meyers, B. C., Green, P. J., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01722-08 · Cited by 134
Wang, M., Tan, L., Dijkstra, M. K., van Lom, K., Robertus, J. L., Harms, G., Blokzijl, T., Kooistra, K., Veer, M. B. V., Rosati, S., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2333 · Cited by 115
miR‐155/BIC as an oncogenic microRNA
Tam, W., & Dahlberg, J. E. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20282 · Cited by 113
Pichler, K., Schneider, G., & Grassmann, R. (2008) · Retrovirology · doi:10.1186/1742-4690-5-100 · Cited by 109
Mirnas and Their Potential For Use Against Cancer and Other Diseases
Tili, E., Michaille, J., Gandhi, V. V., Plunkett, W. K., Sampath, D., & Calin, G. A. (2007) · Future Oncology · doi:10.2217/14796694.3.5.521 · Cited by 108
Self-citationA role for AID in chromosome translocations between c-myc and the IgH variable region
Dorsett, Y., Robbiani, D. F., Janković, M., Reina‐San‐Martin, B., Eisenreich, T., & Nussenzweig, M. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070884 · Cited by 106
Expression and function of micro RNAs in immune cells during normal or disease state
Tili, E., Michaille, J., & Calin, G. A. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.73 · Cited by 105
Self-citationRomania, P., Lulli, V., Pelosi, E., Biffoni, M., Peschle, C., & Marziali, G. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07382.x · Cited by 91
Tran, P. T., Fan, A. C., Bendapudi, P. K., Koh, S., Komatsubara, K. M., Chen, J., Horng, G., Bellovin, D. I., Giuriato, S., Wang, C. S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002125 · Cited by 90
Rahadiani, N., Takakuwa, T., Tresnasari, K., Morii, E., & Aozasa, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.007 · Cited by 60
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Circulating MicroRNAs in Patients With Coronary Artery Disease
Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C. W., Röxe, T., Müller-Ardogan, M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215566 · Cited by 1,233
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 624
Haemolysis during sample preparation alters microRNA content of plasma
Kirschner, M. B., Kao, S. C., Edelman, J. J., Armstrong, N. J., Vallely, M. P., van Zandwijk, N., & Reid, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024145 · Cited by 569
Metadata
- Authors
- Tili, E., Croce, C. M., & Michaille, J.-J.
- Venue
- International Reviews of Immunology
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 28
- Issue
- 5
- Pages
- 264-284
- ISSN
- 0883-0185 (ISSN-L)
- 1563-5244
- OpenAlex
- W2123505066
- Cited by
- 340
- References
- 57
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.